Pharmaceuticals - Union Register

  

List of refusals for human medicinal products

Kronos

Product name: Kronos
Active substance: Propentofylline
Indication: Treatment of Alzheimer disease
Marketing Authorisation Holder: Aventis Pharma Deutschland GmbH

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/10/1999 Centralised - Refusal of marketing authorisation EMEA/H/C/146 (1999)3180 of 5/10/1999